Clinical Trial Update: GnRHA Therapy and Ovarian Preservation in Pediatric Cancer Patient [NA]

View source ↗

Summary

Clinical trial update indicates termination of a GnRH agonist therapy trial for ovarian preservation in pediatric cancer patients undergoing chemoradiation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Childhood Cancer

Drugs mentioned

• Gonadotropin-releasing hormone agonist therapy

Snippet

Sponsor: University of Kentucky | Conditions: Cancer, Chemoradiation | NA | Status: TERMINATED